vs

Side-by-side financial comparison of INNOVATIVE INDUSTRIAL PROPERTIES INC (IIPR) and RIGEL PHARMACEUTICALS INC (RIGL). Click either name above to swap in a different company.

RIGEL PHARMACEUTICALS INC is the larger business by last-quarter revenue ($69.8M vs $66.7M, roughly 1.0× INNOVATIVE INDUSTRIAL PROPERTIES INC). RIGEL PHARMACEUTICALS INC runs the higher net margin — 384.0% vs 47.8%, a 336.3% gap on every dollar of revenue. On growth, RIGEL PHARMACEUTICALS INC posted the faster year-over-year revenue change (21.2% vs -13.1%). Over the past eight quarters, RIGEL PHARMACEUTICALS INC's revenue compounded faster (53.7% CAGR vs -6.0%).

Oxford Properties is a Canadian multinational corporation, with operations in real estate investment, development and property management. Its portfolio includes office, retail, industrial, multi-residential, life sciences and hotel assets. Established privately in 1960 and later wholly owned by the Ontario Municipal Employees Retirement System (OMERS) since 2003, the company is headquartered in Toronto with regional head offices in New York City, London, Australia, Singapore and Luxembourg. ...

Rigel Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing targeted small molecule therapies for autoimmune, inflammatory, and hematologic diseases. Its approved flagship product treats adult immune thrombocytopenia, with primary operations and core markets in the United States, addressing unmet medical needs for underserved patient groups.

IIPR vs RIGL — Head-to-Head

Bigger by revenue
RIGL
RIGL
1.0× larger
RIGL
$69.8M
$66.7M
IIPR
Growing faster (revenue YoY)
RIGL
RIGL
+34.3% gap
RIGL
21.2%
-13.1%
IIPR
Higher net margin
RIGL
RIGL
336.3% more per $
RIGL
384.0%
47.8%
IIPR
Faster 2-yr revenue CAGR
RIGL
RIGL
Annualised
RIGL
53.7%
-6.0%
IIPR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IIPR
IIPR
RIGL
RIGL
Revenue
$66.7M
$69.8M
Net Profit
$31.8M
$268.1M
Gross Margin
91.5%
Operating Margin
47.8%
33.2%
Net Margin
47.8%
384.0%
Revenue YoY
-13.1%
21.2%
Net Profit YoY
-20.4%
1769.2%
EPS (diluted)
$1.07
$14.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IIPR
IIPR
RIGL
RIGL
Q4 25
$66.7M
$69.8M
Q3 25
$64.7M
$69.5M
Q2 25
$62.9M
$101.7M
Q1 25
$71.7M
$53.3M
Q4 24
$76.7M
$57.6M
Q3 24
$76.5M
$55.3M
Q2 24
$79.8M
$36.8M
Q1 24
$75.5M
$29.5M
Net Profit
IIPR
IIPR
RIGL
RIGL
Q4 25
$31.8M
$268.1M
Q3 25
$29.3M
$27.9M
Q2 25
$26.0M
$59.6M
Q1 25
$31.1M
$11.4M
Q4 24
$40.0M
$14.3M
Q3 24
$40.2M
$12.4M
Q2 24
$42.0M
$-1.0M
Q1 24
$39.4M
$-8.2M
Gross Margin
IIPR
IIPR
RIGL
RIGL
Q4 25
91.5%
Q3 25
93.2%
Q2 25
95.6%
Q1 25
91.7%
Q4 24
89.9%
Q3 24
85.5%
Q2 24
92.4%
Q1 24
93.1%
Operating Margin
IIPR
IIPR
RIGL
RIGL
Q4 25
47.8%
33.2%
Q3 25
45.5%
40.9%
Q2 25
45.9%
60.1%
Q1 25
47.4%
23.9%
Q4 24
54.7%
28.9%
Q3 24
54.8%
25.4%
Q2 24
53.1%
1.2%
Q1 24
55.7%
-23.6%
Net Margin
IIPR
IIPR
RIGL
RIGL
Q4 25
47.8%
384.0%
Q3 25
45.3%
40.2%
Q2 25
41.4%
58.6%
Q1 25
43.3%
21.5%
Q4 24
52.2%
24.9%
Q3 24
52.6%
22.5%
Q2 24
52.6%
-2.8%
Q1 24
52.3%
-27.9%
EPS (diluted)
IIPR
IIPR
RIGL
RIGL
Q4 25
$1.07
$14.11
Q3 25
$0.97
$1.46
Q2 25
$0.86
$3.28
Q1 25
$1.03
$0.63
Q4 24
$1.35
$0.82
Q3 24
$1.37
$0.70
Q2 24
$1.44
$-0.06
Q1 24
$1.36
$-0.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IIPR
IIPR
RIGL
RIGL
Cash + ST InvestmentsLiquidity on hand
$47.6M
$155.0M
Total DebtLower is stronger
$393.7M
$52.5M
Stockholders' EquityBook value
$1.8B
$391.5M
Total Assets
$2.4B
$513.6M
Debt / EquityLower = less leverage
0.21×
0.13×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IIPR
IIPR
RIGL
RIGL
Q4 25
$47.6M
$155.0M
Q3 25
$41.9M
$137.1M
Q2 25
$104.9M
$108.4M
Q1 25
$133.3M
$77.1M
Q4 24
$151.2M
$77.3M
Q3 24
$172.4M
$61.1M
Q2 24
$160.9M
$49.1M
Q1 24
$173.5M
$49.5M
Total Debt
IIPR
IIPR
RIGL
RIGL
Q4 25
$393.7M
$52.5M
Q3 25
$60.0M
Q2 25
$60.0M
Q1 25
$60.0M
Q4 24
$60.0M
Q3 24
$60.0M
Q2 24
$60.0M
Q1 24
$60.0M
Stockholders' Equity
IIPR
IIPR
RIGL
RIGL
Q4 25
$1.8B
$391.5M
Q3 25
$1.9B
$117.6M
Q2 25
$1.9B
$81.9M
Q1 25
$1.9B
$18.6M
Q4 24
$1.9B
$3.3M
Q3 24
$1.9B
$-14.6M
Q2 24
$1.9B
$-29.9M
Q1 24
$2.0B
$-31.7M
Total Assets
IIPR
IIPR
RIGL
RIGL
Q4 25
$2.4B
$513.6M
Q3 25
$2.3B
$242.5M
Q2 25
$2.3B
$206.7M
Q1 25
$2.4B
$176.0M
Q4 24
$2.4B
$164.0M
Q3 24
$2.4B
$139.4M
Q2 24
$2.4B
$128.4M
Q1 24
$2.4B
$126.5M
Debt / Equity
IIPR
IIPR
RIGL
RIGL
Q4 25
0.21×
0.13×
Q3 25
0.51×
Q2 25
0.73×
Q1 25
3.23×
Q4 24
18.25×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IIPR
IIPR
RIGL
RIGL
Operating Cash FlowLast quarter
$198.2M
$22.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
6.22×
0.08×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IIPR
IIPR
RIGL
RIGL
Q4 25
$198.2M
$22.0M
Q3 25
$45.6M
$24.0M
Q2 25
$48.4M
$30.5M
Q1 25
$54.2M
$-893.0K
Q4 24
$258.4M
$14.5M
Q3 24
$64.9M
$21.7M
Q2 24
$64.2M
$302.0K
Q1 24
$71.6M
$-5.0M
Cash Conversion
IIPR
IIPR
RIGL
RIGL
Q4 25
6.22×
0.08×
Q3 25
1.56×
0.86×
Q2 25
1.86×
0.51×
Q1 25
1.75×
-0.08×
Q4 24
6.46×
1.01×
Q3 24
1.61×
1.75×
Q2 24
1.53×
Q1 24
1.82×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons